PMID: 25774480Mar 17, 2015Paper

Long-term toxicity of chemotherapy and radiotherapy in lymphoma survivors: optimizing treatment for individual patients

Clinical Advances in Hematology & Oncology : H&O
D C Hodgson

Abstract

Lymphoma treatment has evolved to reflect the fact that even when cure is achieved, significant chronic or late-onset toxicity can vitiate long-term patient outcomes. Previously, the sole focus of treatment was on maximizing cure rates. Now, the emphasis is on titrating treatment intensity to retain or improve cure rates while limiting treatment-associated late effects. To accomplish this on an individual basis remains clinically challenging. Most of the agents used in the treatment of Hodgkin and non-Hodgkin lymphoma have the potential to produce late--manifesting toxicities such as cardiac dysfunction, second malignancy, and infertility. This review outlines some of the evidence regarding late effects of chemotherapy and radiation for lymphoma, with emphasis on how understanding individual patient characteristics can affect the potential late toxicity of different treatment options.

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
A W Sandra van den Belt-DuseboutF E van Leeuwen
[Rinshō ketsueki] The Japanese journal of clinical hematology
Motoko Yamaguchi
© 2021 Meta ULC. All rights reserved